Regencell Bioscience Holdings Limited
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2019 | $-391.0K | $-391.0K | — | — |
| FY2020 | $-726.6K | $-844.4K | $117.8K | — |
| FY2021 | $-767.3K | $-767.3K | — | — |
| FY2022 | $-5.3M | $-6.0M | $780.9K | $2.8M |
| FY2023 | $-5.0M | $-5.0M | $27.4K | $922.6K |
| FY2024 | $-4.0M | $-4.0M | $5.4K | $449.3K |
| FY2025 | $-3.1M | $-3.3M | $152.7K | $244.8K |